519 related articles for article (PubMed ID: 27217001)
1. Synthesis and anti-proliferative activity of fluoro-substituted chalcones.
Burmaoglu S; Algul O; Anıl DA; Gobek A; Duran GG; Ersan RH; Duran N
Bioorg Med Chem Lett; 2016 Jul; 26(13):3172-3176. PubMed ID: 27217001
[TBL] [Abstract][Full Text] [Related]
2. Novel 1-(7-ethoxy-1-benzofuran-2-yl) substituted chalcone derivatives: Synthesis, characterization and anticancer activity.
Coskun D; Erkisa M; Ulukaya E; Coskun MF; Ari F
Eur J Med Chem; 2017 Aug; 136():212-222. PubMed ID: 28494257
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of modified chalcone based p53 stabilizing agents.
Iftikhar S; Khan S; Bilal A; Manzoor S; Abdullah M; Emwas AH; Sioud S; Gao X; Chotana GA; Faisal A; Saleem RSZ
Bioorg Med Chem Lett; 2017 Sep; 27(17):4101-4106. PubMed ID: 28743509
[TBL] [Abstract][Full Text] [Related]
4. Novel anthraquinone based chalcone analogues containing an imine fragment: synthesis, cytotoxicity and anti-angiogenic activity.
Kolundžija B; Marković V; Stanojković T; Joksović L; Matić I; Todorović N; Nikolić M; Joksović MD
Bioorg Med Chem Lett; 2014 Jan; 24(1):65-71. PubMed ID: 24332490
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, biological evaluation and molecular docking studies of aminochalcone derivatives as potential anticancer agents by targeting tubulin colchicine binding site.
Wang G; Peng Z; Zhang J; Qiu J; Xie Z; Gong Z
Bioorg Chem; 2018 Aug; 78():332-340. PubMed ID: 29627654
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and activity of novel sorafenib analogues bearing chalcone unit.
Wang M; Xu S; Wu C; Liu X; Tao H; Huang Y; Liu Y; Zheng P; Zhu W
Bioorg Med Chem Lett; 2016 Nov; 26(22):5450-5454. PubMed ID: 27777009
[TBL] [Abstract][Full Text] [Related]
7. Design and multi-step synthesis of chalcone-polyamine conjugates as potent antiproliferative agents.
Rioux B; Pouget C; Fidanzi-Dugas C; Gamond A; Laurent A; Semaan J; Pinon A; Champavier Y; Léger DY; Liagre B; Duroux JL; Fagnère C; Sol V
Bioorg Med Chem Lett; 2017 Sep; 27(18):4354-4357. PubMed ID: 28838697
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and anti-proliferative activity of a novel 1,2,3-triazole tethered chalcone acetamide derivatives.
Vanaparthi S; Bantu R; Jain N; Janardhan S; Nagarapu L
Bioorg Med Chem Lett; 2020 Aug; 30(16):127304. PubMed ID: 32631524
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of novel marine bromopyrrole alkaloid-based hybrids as anticancer agents.
Rane RA; Sahu NU; Gutte SD; Mahajan AA; Shah CP; Bangalore P
Eur J Med Chem; 2013 May; 63():793-9. PubMed ID: 23584542
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and anti-cancer activity evaluation of novel prenylated and geranylated chalcone natural products and their analogs.
Wang HM; Zhang L; Liu J; Yang ZL; Zhao HY; Yang Y; Shen D; Lu K; Fan ZC; Yao QW; Zhang YM; Teng YO; Peng Y
Eur J Med Chem; 2015 Mar; 92():439-48. PubMed ID: 25590864
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, characterization, and anticancer activity of a novel series of O-substituted chalcone derivatives.
Ngameni B; Cedric K; Mbaveng AT; Erdoğan M; Simo I; Kuete V; Daştan A
Bioorg Med Chem Lett; 2021 Mar; 35():127827. PubMed ID: 33508467
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of novel synthetic chalcone derivatives as anti-tumor agents targeting Cat L and Cat K.
Wang Y; Xue S; Li R; Zheng Z; Yi H; Li Z
Bioorg Med Chem; 2018 Jan; 26(1):8-16. PubMed ID: 29223717
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological evaluation of novel ligustrazine-chalcone derivatives as potential anti-triple negative breast cancer agents.
Luo Y; Wu W; Zha D; Zhou W; Wang C; Huang J; Chen S; Yu L; Li Y; Huang Q; Zhang J; Zhang C
Bioorg Med Chem Lett; 2021 Sep; 47():128230. PubMed ID: 34186178
[TBL] [Abstract][Full Text] [Related]
14. Chalcone derivatives targeting mitosis: synthesis, evaluation of antitumor activity and lipophilicity.
Pinto P; Machado CM; Moreira J; Almeida JDP; Silva PMA; Henriques AC; Soares JX; Salvador JAR; Afonso C; Pinto M; Bousbaa H; Cidade H
Eur J Med Chem; 2019 Dec; 184():111752. PubMed ID: 31610374
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and Cytotoxic Activities of Difluoro-Dimethoxy Chalcones.
Yamali C; Gul HI; Ozgun DO; Sakagam H; Umemura N; Kazaz C; Gul M
Anticancer Agents Med Chem; 2017; 17(10):1426-1433. PubMed ID: 28356013
[TBL] [Abstract][Full Text] [Related]
16. Biological evaluation of indolizine-chalcone hybrids as new anticancer agents.
Park S; Kim EH; Kim J; Kim SH; Kim I
Eur J Med Chem; 2018 Jan; 144():435-443. PubMed ID: 29288944
[TBL] [Abstract][Full Text] [Related]
17. Anti-proliferative effect of chalcone derivatives through inactivation of NF-κB in human cancer cells.
Venkateswararao E; Sharma VK; Yun J; Kim Y; Jung SH
Bioorg Med Chem; 2014 Jul; 22(13):3386-92. PubMed ID: 24835787
[TBL] [Abstract][Full Text] [Related]
18. Antitumor agents. Part 202: novel 2'-amino chalcones: design, synthesis and biological evaluation.
Xia Y; Yang ZY; Xia P; Bastow KF; Nakanishi Y; Lee KH
Bioorg Med Chem Lett; 2000 Apr; 10(8):699-701. PubMed ID: 10782667
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological evaluation of pyridine-chalcone derivatives as novel microtubule-destabilizing agents.
Xu F; Li W; Shuai W; Yang L; Bi Y; Ma C; Yao H; Xu S; Zhu Z; Xu J
Eur J Med Chem; 2019 Jul; 173():1-14. PubMed ID: 30981112
[TBL] [Abstract][Full Text] [Related]
20. Anti-breast cancer activity of heteroaryl chalcone derivatives.
Solomon VR; Lee H
Biomed Pharmacother; 2012 Apr; 66(3):213-20. PubMed ID: 22440895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
